Vault-13

VOR BIOPHARMA INC VOR

COM NEW · Common Stock · CUSIP 929033207

55 institutional holders +19 vs Q3 2025
25,547,12325.5m shares reported held*
$332.0mreported value*
28 new 19 added 2 reduced 10 sold out net bought ≈ $270.4m (+20.8m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $13.00. Options: 6 managers hold calls ($16.2m notional), 4 hold puts ($5.9m).

Trends to Q4 2025

Institutional holders

Managers reporting a position, each quarter

0204060Q1 25: 1Q2 25: 1Q3 25: 36Q4 25: 5555Q1 25Q2 25Q3 25Q4 25
Numbers
QuarterHolders
Q1 20251
Q2 20251
Q3 202536
Q4 202555

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
50050Q2 25: 0 bought or addedQ2 25: 0 cut or sold outQ2 25Q3 25: 36 bought or addedQ3 25: 1 cut or sold outQ3 25Q4 25: 47 bought or addedQ4 25: 12 cut or sold outQ4 25
Numbers
QuarterBought or addedCut or sold out
Q2 202500
Q3 2025361
Q4 20254712

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$100m$200m$300m$400mQ1 25 calls: $0Q1 25 puts: $0Q1 25P/C —Q2 25 calls: $0Q2 25 puts: $0Q2 25P/C —Q3 25 calls: $360.9mQ3 25 puts: $57.8mQ3 25P/C 0.16Q4 25 calls: $16.2mQ4 25 puts: $5.9mQ4 25P/C 0.37
Numbers
QuarterCallsPutsP/C
Q1 2025$0$0—
Q2 2025$0$0—
Q3 2025$360.9m$57.8m0.16
Q4 2025$16.2m$5.9m0.37

Biggest buyers

RA CAPITAL MANAGEMENT, L.P. Added +3,422,697+3.4m
FCPM III SERVICES B.V. Added +3,237,714+3.2m
Frazier Life Sciences Management, L.P. New +2,543,939+2.5m
FMR LLC Added +2,289,662+2.3m
Paradigm Biocapital Advisors LP New +1,750,000+1.8m
Venrock Adviser, LLC Added +1,443,800+1.4m
GREAT POINT PARTNERS LLC New +1,370,107+1.4m
Caligan Partners LP New +925,067+925.1k
VANGUARD GROUP INC Added +665,060+665.1k
BlackRock, Inc. Added +431,106+431.1k

Biggest sellers

Ariose Capital Management Ltd Sold out -110,173-110.2k
TANG CAPITAL MANAGEMENT LLC Sold out -50,000-50.0k
Woodline Partners LP Sold out -27,363-27.4k
Polymer Capital Management (HK) LTD Sold out -21,248-21.2k
RENAISSANCE TECHNOLOGIES LLC Sold out -14,600-14.6k
Virtu Financial LLC Sold out -8,104-8.1k
BRIDGEWAY CAPITAL MANAGEMENT, LLC Sold out -6,250-6.2k
Scientech Research LLC Sold out -6,097-6.1k
BNP PARIBAS FINANCIAL MARKETS Reduced -5,784-5.8k
Trustees of Columbia University in the City of New York Sold out -4,595-4.6k

Biggest calls

SUSQUEHANNA INTERNATIONAL GROUP, LLP Reduced $13.1m999.3k shares
GROUP ONE TRADING LLC Reduced $2.4m185.0k shares
Hudson Bay Capital Management LP Unchanged $277.9k21.2k shares
CITADEL ADVISORS LLC Added $211.4k16.2k shares
JANE STREET GROUP, LLC Reduced $173.0k13.2k shares
Belvedere Trading LLC Reduced $37.3k57.4k shares

Biggest puts

SUSQUEHANNA INTERNATIONAL GROUP, LLP Reduced $4.7m355.9k shares
GROUP ONE TRADING LLC Reduced $1.1m85.0k shares
CITADEL ADVISORS LLC Added $166.4k12.7k shares
Belvedere Trading LLC Reduced $130200 shares

Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
RA CAPITAL MANAGEMENT, L.P. 13D · may seek influence no change · filed 2026-07-21
Stated purposeItem 4 of the Statement is hereby amended and supplemented as follows: Effective July 6, 2026, Andrew Levin resigned from the Board of Directors of the Issuer. Full filing
19.9% no change 12.9m≈ $238.2m 2026-07-21
Reprogrammed Interchange LLC 13D · may seek influence filed 2025-10-17
Stated purposeItem 4 of Schedule 13D is hereby amended and supplemented as follows: From October 15, 2025 through October 16, 2025, Reprogrammed Interchange LLC sold the following shares of Vor Biopharma Inc. in open market transactions, resulting in a decrease in the number of shares of Common Stock beneficially owned by the Reporting Persons by more than one percent of the outstanding shares of Common Stock of the Issuer. 1. 71,655 shares on October 15, 2025, at a weighted average per share sale price of $31.9196. 2. 2,021 shares on October 16, 2025, at a weighted average per share sale price of $30.4548. Full filing
17.6% 1.2m≈ $22.2m 2025-10-17
FMR LLC 13G · institution +2.9 pts · filed 2026-08-07 12.0% +2.9 pts 6.5m≈ $119.8m 2026-08-07
TCG Crossover GP II, LLC 13G · passive investor new · filed 2026-04-01 10.5% new 5.7m≈ $104.4m 2026-04-01
ForGrowth III PA B.V. 13D · may seek influence no change · filed 2025-12-23
Stated purposeThe Reporting Persons acquired their shares of Common Stock as an investment in the ordinary course of business. On December 18, 2025, Wouter Joustra, a General Partner at Forbion Capital, was appointed to the Issuer's board of directors. The Reporting Persons, either directly or indirectly through Mr. Joustra, may engage in discussions from time to time with the Issuer's board of directors, the Issuer's management or the Issuer's other stockholders. These discussions may be with respect to (i) acquiring or disposing of the shares or other securities of the Issuer; (ii) maintaining or changing the Issuer's business, operations, governance, management, strategy or capitalization; or (iii) implementing transactions that may relate to or may result in any matter set forth in paragraphs (a) t… Full filing
10.0% no change 10.2m≈ $119.7m 2025-12-23
Venrock Healthcare Capital Partners III, L.P. 13G · passive investor no change · filed 2026-08-14 9.9% no change 5.7m≈ $104.5m 2026-08-14
Verve Capital Ltd 13G · passive investor -3.0 pts · filed 2026-08-13 6.3% -3.0 pts 3.4m≈ $62.8m 2026-08-13
BlackRock, Inc. 13G · institution new · filed 2026-07-30 5.7% new 3.1m≈ $57.1m 2026-07-30

Fell to 5% or below in the last year: Frazier Life Sciences Public Fund, L.P. (4.2%, 2026-08-14), Qiming Venture Partners VIII-HC, L.P. (2.0%, 2026-05-06), GREAT POINT PARTNERS LLC (3.3%, 2026-02-17), Paradigm Biocapital Advisors LP (4.5%, 2026-02-17)

Insider purchases and sales in Q4 2025

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
101Q1 24: 0 buyingQ1 24: 0 sellingQ2 24: 0 buyingQ2 24: 1 sellingQ2 24Q3 24: 0 buyingQ3 24: 0 sellingQ4 24: 0 buyingQ4 24: 1 sellingQ4 24Q1 25: 0 buyingQ1 25: 1 sellingQ2 25: 0 buyingQ2 25: 0 sellingQ2 25Q3 25: 0 buyingQ3 25: 0 sellingQ4 25: 0 buyingQ4 25: 1 sellingQ4 25
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q1 20240—0——
Q2 20240—1$20.4k$20.4k
Q3 20240—0——
Q4 20240—1$12.9k$12.9k
Q1 20250—1$6.7k$6.7k
Q2 20250—0——
Q3 20250—0——
Q4 20250—1$33.7m—
DateInsiderTradeSharesPrice ValueTheir holding
2025-10-30 RA Capital Healthcare Fund LP +3 Director · See footnotes Sold 24,579 $25.12 $617.4k24.6k shares -3%
2025-10-29 RA Capital Healthcare Fund LP +3 Director · See footnotes Sold 251,518 $25.22 $6.3m251.5k shares -24%
2025-10-28 RA Capital Healthcare Fund LP +3 Director · See footnotes Sold 124,311 $27.42 $3.4m124.3k shares -10%
2025-10-27 RA Capital Healthcare Fund LP +3 Director · See footnotes Sold 90,941 $28.12 $2.6m90.9k shares -7%
2025-10-24 RA Capital Healthcare Fund LP +3 Director · See footnotes Sold 53,345 $28.01 $1.5m53.3k shares -4%
2025-10-23 RA Capital Healthcare Fund LP +3 Director · See footnotes Sold 76,880 $28.01 $2.2m76.9k shares -6%
2025-10-21 RA Capital Healthcare Fund LP +4 Director · See footnotes Sold 25,027 $28.11 $703.5k25.0k shares -2%
2025-10-21 Hoffman Reid +1 10% owner Sold 200 $30.08 $6.0k200 shares -<1%
2025-10-20 RA Capital Healthcare Fund LP +4 Director · See footnotes Sold 92,023 $29.67 $2.7m92.0k shares -100%
2025-10-20 Hoffman Reid +1 10% owner Sold 11,616 $30.05 $349.1k11.6k shares -1%
2025-10-17 RA Capital Healthcare Fund LP +4 Director · See footnotes Sold 260,859 $29.39 $7.7m260.9k shares -94%
2025-10-17 Hoffman Reid +1 10% owner Sold 25,717 $30.25 $778.0k25.7k shares -2%
2025-10-16 RA Capital Healthcare Fund LP +4 Director · See footnotes Sold 151,803 $29.45 $4.5m151.8k shares -72%
2025-10-16 Hoffman Reid +1 10% owner Sold 2,021 $30.45 $61.5k2.0k shares -<1%
2025-10-15 Hoffman Reid +1 10% owner Sold 71,655 $31.92 $2.3m71.7k shares -6%
2025-10-15 RA Capital Healthcare Fund LP +4 Director · See footnotes Sold 51,363 $30.55 $1.6m51.4k shares -38%
2025-10-14 Hoffman Reid +1 10% owner Sold 33,668 $30.32 $1.0m33.7k shares -3%
2025-10-13 Hoffman Reid +1 10% owner Sold 22,006 $32.44 $713.8k22.0k shares -2%
2025-10-10 Hoffman Reid +1 10% owner Sold 40,983 $30.97 $1.3m41.0k shares -3%
2025-10-09 Hoffman Reid +1 10% owner Sold 48,884 $32.07 $1.6m48.9k shares -3%
2025-10-08 Hoffman Reid +1 10% owner Sold 75,262 $33.86 $2.5m75.3k shares -5%
2025-10-07 Hoffman Reid +1 10% owner Sold 27,624 $33.84 $934.8k27.6k shares -2%
2025-10-06 Hoffman Reid +1 10% owner Sold 70,763 $37.01 $2.6m70.8k shares -4%
2025-10-03 Hoffman Reid +1 10% owner Sold 7,901 $37.83 $298.9k7.9k shares -0%
2025-10-02 Hoffman Reid +1 10% owner Sold 32,451 $39.83 $1.3m32.5k shares -2%
2025-10-01 Hoffman Reid +1 10% owner Sold 1,400 $39.19 $54.9k1.4k shares -<1%

Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).

Holders, Q4 2025

#ManagerLocationShares Value% of their portfolioChangeShares change
1 RA CAPITAL MANAGEMENT, L.P. 0.72% of their portfolio BOSTON, MA 5,404,9985.4m $70.7m $70.7m 0.72% Added +3.4m +3,422,697
2 FCPM III SERVICES B.V. 6.20% of their portfolio NAARDEN, P7 3,617,3543.6m $47.3m $47.3m 6.20% Added +3.2m +3,237,714
3 Frazier Life Sciences Management, L.P. 0.89% of their portfolio PALO ALTO, CA 2,543,9392.5m $33.3m $33.3m 0.89% New
4 FMR LLC 0.00% of their portfolio BOSTON, MA 2,526,1702.5m $33.0m $33.0m 0.00% Added +2.3m +2,289,662
5 Venrock Adviser, LLC 1.26% of their portfolio NEW YORK, NY 1,943,7661.9m $25.4m $25.4m 1.26% Added +1.4m +1,443,800
6 Paradigm Biocapital Advisors LP 0.61% of their portfolio NEW YORK, NY 1,750,0001.8m $22.9m $22.9m 0.61% New
7 GREAT POINT PARTNERS LLC 5.81% of their portfolio Greenwich, CT 1,370,1071.4m $17.9m $17.9m 5.81% New
8 NEXTBio Capital Management LP 7.67% of their portfolio AUSTIN, TX 999,9671,000.0k $13.1m $13.1m 7.67% First filing
9 Caligan Partners LP 0.91% of their portfolio NEW YORK, NY 925,067925.1k $10.0m $10.0m 0.91% New
10 VANGUARD GROUP INC 0.00% of their portfolio Valley Forge, PA 770,250770.2k $10.1m $10.1m 0.00% Added +665.1k +665,060
11 BlackRock, Inc. 0.00% of their portfolio New York, NY 465,636465.6k $6.1m $6.1m 0.00% Added +431.1k +431,106
12 CITADEL ADVISORS LLC 0.00% of their portfolio MIAMI, FL 433,894433.9k $5.7m $5.7m 0.00% Added +428.2k +428,208
13 SPHERA FUNDS MANAGEMENT LTD. 1.12% of their portfolio TEL AVIV, L3 410,417410.4k $5.4m $5.4m 1.12% New
14 Laurion Capital Management LP 0.28% of their portfolio NEW YORK, NY 317,243317.2k $4.1m $4.1m 0.28% New
15 UBS Group AG 0.00% of their portfolio ZURICH, V8 292,118292.1k $3.8m $3.8m 0.00% Added +216.2k +216,209
16 FINDELL CAPITAL MANAGEMENT LLC 1.00% of their portfolio New York, NY 231,000231.0k $3.0m $3.0m 1.00% New
17 MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio NEW YORK, NY 224,534224.5k $2.9m $2.9m 0.00% Added +199.8k +199,770
18 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 185,808185.8k $2.4m $2.4m 0.00% Added +158.4k +158,416
19 TUDOR INVESTMENT CORP ET AL 0.01% of their portfolio STAMFORD, CT 167,673167.7k $2.2m $2.2m 0.01% New
20 AMERIPRISE FINANCIAL INC 0.00% of their portfolio MINNEAPOLIS, MN 163,061163.1k $2.1m $2.1m 0.00% New
21 GOLDMAN SACHS GROUP INC 0.00% of their portfolio NEW YORK, NY 145,640145.6k $1.9m $1.9m 0.00% Added +129.9k +129,854
22 Logos Global Management LP 0.09% of their portfolio San Francisco, CA 100,000100.0k $1.3m $1.3m 0.09% New
23 JANE STREET GROUP, LLC 0.00% of their portfolio NEW YORK, NY 91,81091.8k $1.2m $1.2m 0.00% Added +75.1k +75,057
24 STATE STREET CORP 0.00% of their portfolio BOSTON, MA 91,05391.1k $1.2m $1.2m 0.00% Added +82.0k +81,999
25 JOHNSON & JOHNSON 0.13% of their portfolio NEW BRUNSWICK, NJ 53,73253.7k $702.8k $702.8k 0.13% New
26 NORTHERN TRUST CORP 0.00% of their portfolio CHICAGO, IL 38,94638.9k $509.4k $509.4k 0.00% New
27 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 28,46328.5k $372.3k $372.3k 0.00% Added +24.0k +24,007
28 Engineers Gate Manager LP 0.00% of their portfolio NEW YORK, NY 28,20428.2k $368.9k $368.9k 0.00% New
29 Quadrature Capital Ltd 0.00% of their portfolio LONDON, X0 26,79126.8k $350.4k $350.4k 0.00% New
30 Sarissa Capital Management LP 0.15% of their portfolio GREENWICH, CT 25,39925.4k $332.2k $332.2k 0.15% Unchanged
31 Bollard Group LLC 0.01% of their portfolio BOSTON, MA 23,98724.0k $314.0k $314.0k 0.01% Added +21.2k +21,210
32 OMERS ADMINISTRATION Corp 0.00% of their portfolio TORONTO, A6 20,70020.7k $270.8k $270.8k 0.00% New
33 Squarepoint Ops LLC 0.00% of their portfolio NEW YORK, NY 18,45918.5k $241.4k $241.4k 0.00% Added +13.7k +13,730
34 XTX Topco Ltd 0.01% of their portfolio LONDON, X0 17,54217.5k $229.4k $229.4k 0.01% New
35 INDEPENDENT FINANCIAL GROUP, LLC 0.00% of their portfolio SAN DIEGO, CA 17,00017.0k $222.4k $222.4k 0.00% New
36 SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio BALA CYNWYD, PA 14,81914.8k $193.8k $193.8k 0.00% New
37 Persistent Asset Partners Ltd 0.07% of their portfolio HONG KONG, K3 10,79810.8k $141.2k $141.2k 0.07% New
38 Shay Capital LLC 0.02% of their portfolio NEW YORK, NY 10,74510.7k $140.5k $140.5k 0.02% New
39 Susquehanna Portfolio Strategies, LLC 0.00% of their portfolio Bala Cynwyd, PA 10,20710.2k $133.5k $133.5k 0.00% New
40 Chung Wu Investment Group, LLC 0.09% of their portfolio SUGAR LAND, TX 8,3008.3k $108.6k $108.6k 0.09% New
41 CITIGROUP INC 0.00% of their portfolio NEW YORK, NY 6,3406.3k $82.9k $82.9k 0.00% New
42 Hudson Bay Capital Management LP 0.00% of their portfolio STAMFORD, CT 5,1105.1k $66.8k $66.8k 0.00% New
43 China Universal Asset Management Co., Ltd. 0.00% of their portfolio SHANGHAI, F4 2,7462.7k $35.9k $35.9k 0.00% New
44 JPMORGAN CHASE & CO 0.00% of their portfolio NEW YORK, NY 2,3122.3k $30.2k $30.2k 0.00% Added +2.2k +2,156
45 Tower Research Capital LLC (TRC) 0.00% of their portfolio NEW YORK, NY 1,7291.7k $22.6k $22.6k 0.00% Added +1.7k +1,725
46 BARCLAYS PLC 0.00% of their portfolio LONDON, X0 1,3991.4k $18.3k $18.3k 0.00% New
47 Mirae Asset Global Investments Co., Ltd. 0.00% of their portfolio SEOUL, M5 819819 $10.7k $10.7k 0.00% New
48 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 396396 $5.2k $5.2k 0.00% Reduced -4.4k -4,358
49 GF FUND MANAGEMENT CO. LTD. 0.00% of their portfolio GUANGZHOU, F4 330330 $4.3k $4.3k 0.00% New
50 BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio PARIS, I0 291291 $3.8k $3.8k 0.00% Reduced -5.8k -5,784
51 MAI Capital Management 0.00% of their portfolio INDEPENDENCE, OH 4040 $524 $524 0.00% Unchanged
52 ROYAL BANK OF CANADA 0.00% of their portfolio TORONTO, A6 77 $0 $0 0.00% Added +5 +5
53 Allworth Financial LP 0.00% of their portfolio FOLSOM, CA 33 $40 $40 0.00% Unchanged
54 SBI Securities Co., Ltd. 0.00% of their portfolio TOKYO, M0 33 $39 $39 0.00% Unchanged
55 WELLS FARGO & COMPANY/MN 0.00% of their portfolio SAN FRANCISCO, CA 11 $13 $13 0.00% Unchanged